The article presents a detailed analysis of the clinical studies on the use of chondroprotector (Alflutop) in patients with persistent displacement of the articular disk of the temporomandibular joint in order to prevent the development of secondary osteoarthrosis. The study showed that the inclusion in the therapy chondroprotective action agents allows achieving short-term positive outcomes in most cases, relief of inflammation and pain, as well as improving joint function and stabilization of the thickness of the articular cartilage that provides cushioning function.
No clinical trial protocols linked to this paper
Clinical trials are automatically linked when NCT numbers are found in the paper's title or abstract.PICO Elements
No PICO elements extracted yet. Click "Extract PICO" to analyze this paper.
Paper Details
MeSH Terms
Associated Data
No associated datasets or code repositories found for this paper.
Related Papers
Related paper suggestions will be available in future updates.